The MOLLI 2 System provides a wire-free and radiation-free approach to localising lesions for breast cancer surgery. Credit: Ground Picture / Shutterstock.

The Medical University of South Carolina (MUSC) Hollings Cancer Center in the US is set to deploy MOLLI Surgical’s advanced breast cancer technology, the MOLLI 2 System.

The technology is designed to improve the patient experience and surgical outcomes with its wire-free and radiation-free approach to localising lesions for breast cancer surgery.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

It allows radiologists to mark lesions using the MOLLI Marker, a small localisation device that can be placed up to 30 days before surgery.

This flexibility allows radiologists to optimise their time without the need to coordinate with surgical schedules. Surgeons then use the MOLLI Wand and MOLLI Tablet for reliable lesion detection, which eliminates the traditional wire-guided localisation method.

Hollings Comprehensive Breast Program medical director and surgical oncologist Andrea Abbott said: “MOLLI 2 provides precise feedback while localising the lesion; the information is instantaneous and allows for efficiency and accuracy.

See Also:

“And patients appreciate the flexibility of having the MOLLI Marker placed ahead of time instead of adding another procedure to the day of surgery.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Designed to offer directional 3D guidance, the technology provides surgeons with millimeter precision in locating the marked lesion.

The MOLLI 2 System’s ease of use, reliability, and precision contribute to increased efficiency and an enhanced patient experience.

The integration of the system into the existing workflows and operating rooms at Hollings has been seamless, MOLLI Surgical said.

MOLLI Surgical president and CEO Ananth Ravi said: “MUSC makes a profound impact on its community as the state’s only comprehensive academic health system. Given its wide reach to patients and medical students, we’re honoured to be selected as a partner to provide precision surgery solutions.

“MUSC’s dedication to advancing patient-centric breast cancer care is further affirmed by their adoption of MOLLI 2.”